Neurology Flashcards

1
Q

How are seizures defined?

A

Transient episode of symptoms due to abnormally excessive or synchronous neuronal activity in the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define epilepsy

A

Neurological disorder characterised by recurring seizures
At least two unprovoked seizures occurring more than 24 hours apart OR
One unprovoked seizure and a probability of further seizures similar to the general recurrence risk (at least 60%) after two unprovoked seizures, occurring over the next 10 years OR
Diagnosis of an epilepsy syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define status epilepticus

A

Prolonged convulsive seizure lasting for 5 minutes or longer, or recurrent seizures one after the other without recovery in between

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List causes of epilepsy and risk factors for epilepsy

A

Structural – stroke, trauma, malformation (genetic or acquired)
Genetic
Infectious – due to infection in which seizures are a core symptom (not seizure due to acute infection e.g., meningitis) e.g., tuberculosis, cerebral malaria, HIV
Metabolic – porphyria, pyridoxine deficiency
Immune – anti-NMDA encephalitis

Risk factors:
Prematurity
Complicated febrile seizures
FHx
Head trauma, infections, traumas
Cerebrovascular disease
Dementia and neurodegenerative disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the classification of seizures

A

By area of onset:
Focal – start in a specific area, in one hemisphere
Generalised – involve both hemispheres
Focal to bilateral – begin in one hemisphere but spread to both

Level of awareness – aware, impaired awareness, loss of consciousness (all generalised)

Motor and non-motor

Specific types:
Generalised tonic-clonic – increased tone then jerking, with tongue biting, incontinence, groaning, irregular breathing
Myoclonic – brief, rapid muscle jerks
Atonic – ‘drop attacks’, brief lapses in muscle tone
Absence – brief episodes, blank, staring into space and then abruptly returns to normal, unaware of surroundings and don’t respond

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the rules for driving with epileptic seizures

A

First seizure:
Can’t drive for at least 6 months, 12 months if high-risk for another seizure

Established epilepsy:
Can drive if 12 months seizure-free, or 6 months if seizure was due to medication change
If seizures only during sleep can drive if only had seizures during sleep for past 3 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the pharmacological management of epilepsy

A

Generalised tonic-clonic:
Sodium valproate first line in males or women unable to have children
Lamotrigine or levetiracetam first line for women and girls able to have children, and second line for men

Focal seizures:
Lamotrigine or levetiracetam first line
Second line – carbamazepine

Absence seizures:
Ethosuximide first line
Sodium valproate second line

Myoclonic seizures:
Sodium valproate first line for males or women unable to have children
Levetiracetam first line in women able to have children

Atonic/tonic seizures:
Sodium valproate first line for males and women unable to have children
Lamotrigine for women able to have children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the mechanism of action of anti-epileptic drugs

A

Sodium valproate – increases GABA activity
Carbamazepine – increases refractory period of sodium channels
Lamotrigine – sodium channel blocker
Levetiracetam – binds to SV2A protein to modulate neurotransmitter release (unknown exact mechanism)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List the major side effects of anti-epileptic drugs

A

Sodium valproate:
Increased appetite, weight gain
Alopecia, curly regrowth
P450 enzyme inhibitor
Ataxia
Tremor
Hepatitis
Pancreatitis
Thrombocytopaenia
Teratogenic – neural tube defects (do not used in women of childbearing age)

Carbamazepine:
P450 enzyme inducer
Dizziness and ataxia
Leucopaenia, agranulocytosis
SIADH
Visual disturbance – diplopia

Lamotrigine:
Stevens-Johnson syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which antiepileptic drugs are safe in pregnancy?

A

Lamotrigine and levetiracetam are safest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is status epilepticus managed?

A

A-E assessment
Oxygen
Check BM

IV benzodiazepines – lorazepam or diazepam

(pre-hospital – PR diazepam or buccal midazolam)

Can repeat once after 10-20 minutes
If ongoing can start second-line agent e.g. phenytoin or phenobarbital
If no response within 45 minutes from onset best way to control is with induction of general anaesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the aetiology of cerebrovascular accidents

A

Ischaemic (85%):
Thrombotic
Embolic – AF
Hypoperfusion – cardiac arrest
Cerebral venous sinus thrombosis – venous congestion causes hypoxia

Haemorrhagic:
Intracerebral
Subarachnoid

Risk factors:
General risk factors for CVD – smoking, obesity, hypertension, diabetes
Embolic – AF, carotid artery disease
Thrombosis – COCP, hereditary thrombophilia, malignancy
Haemorrhagic – AV malformation, anticoagulation, hypertension, trauma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the classification of ischaemic strokes

A

Bamford/Oxford classification

Total anterior circulation stroke – middle and anterior cerebral arteries, need to have all of:
Unilateral weakness/sensory loss of face, arm and leg
Homonymous hemianopia
Higher cerebral dysfunction – dysphagia, visuospatial disorder

Partial anterior circulation stroke – smaller divisions of anterior circulation (e.g. upper or lower middle cerebral artery), two of:
Unilateral weakness/sensory loss of face, arm and leg
Homonymous hemianopia
Higher cerebral dysfunction – dysphagia, visuospatial disorder
(or higher dysfunction alone)

Posterior circulation stroke – vertebrobasilar arteries (cerebellum and brainstem), one of:
Cranial nerve palsy and contralateral motor/sensory deficit
Bilateral motor/sensory deficit
Conjugate eye movement disorder
Cerebellar dysfunction e.g. vertigo, nystagmus, ataxia
Isolated homonymous hemianopia

Lacunar stroke – small vessel disease, one of:
Pure sensory or pure motor
Sensorimotor
Ataxic hemiparesis
(no higher dysfunction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the presentation of strokes by vessel affected

A

Anterior cerebral artery – contralateral hemiparesis and sensory loss, legs affected more than arms

Middle cerebral artery – contralateral hemiparesis and sensory loss, arms affected more than legs, contralateral homonymous hemianopia, aphasia

Posterior cerebral artery – contralateral homonymous hemianopia with macular sparing, visual agnosia

Weber’s syndrome (midbrain branches of posterior cerebral artery) – ipsilateral CN III palsy, contralateral weakness of upper and lower extremity

Posterior inferior cerebellar artery (lateral medullary/Wallenberg syndrome) – ipsilateral facial pain and temperature loss, contralateral limb/torso pain and temperature loss, ataxia, nystagmus

Retinal/ophthalmic artery – amaurosis fugax

Basilar artery – ‘locked-in’ syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the initial assessment of suspected stroke

A

Exclude hypoglycaemia

ROSIER score – stroke likely if >0

Non-contrast CT head 1st line investigation (exclude haemorrhage)

Investigations – ECG, U+Es, LFTs, cholesterol, FBC, ESR, coagulation

Swallow assessment within 4 hours – before oral medications, fluid, diet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the presentation of haemorrhagic stroke compared with ischaemic stroke

A

Abrupt onset symptoms and decompensation
Reduced level of consciousness
Headache
Nausea and vomiting
Seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the initial management of strokes

A

O2 as required
Withhold platelets and anticoagulants until CT excluded haemorrhage
If BM low correct, if high can give insulin but avoid hypoglycaemia
IVF as required

Haemorrhagic stroke excluded – give aspirin 300mg orally (if swallow safe) or rectally ASAP

If presenting less than 4.5 hours since symptom onset, symptoms still present and haemorrhage ruled out may be suitable for thrombolysis with alteplase

If presenting within 6 hours of symptom onset offer thrombectomy for confirmed occlusion of proximal anterior circulation on CTA or MRA (with thrombolysis)
Can also give if known to be well between 6-24 hours previously if confirmed proximal anterior circulation occlusion and potential to salvage brain tissue (on CT perfusion or diffusion-weighted MRI)

If not suitable for either give 300mg aspirin for 14 days then 75mg once daily
Aspirin and clopidogrel given for non-cardioembolic minor ischaemic stroke or high risk TIA (ABCD >4), for 21 days then clopidogrel 75mg long term

If haemorrhage on CT – check coagulation screen, stop anticoagulants (consider reversal), neurosurgery referral?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

List indications for urgent CT in suspected stroke

A

Reduced GCS or coma
On anticoagulants
Brainstem signs, bilateral signs, ‘locked-in’
Cerebellar stroke signs with headache or raised ICP symptoms
Severe headache
Stuttering onset
Immunocompromised
Unexplained fever
Signs of raised ICP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

List contraindications to thrombolysis for management of stroke

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Define TIA and stroke

A

Transient ischaemic attack – transient episode (less than 24 hours) of neurologic dysfunction caused by focal brain, spinal cord or retinal ischaemia, without acute infarction (no longer purely time based, even short ischaemia can result in pathological changes)

Stroke – clinical syndrome of presumed vascular origin characterised by rapidly developing signs of focal or global disturbance of cerebral functions which persist (longer than 24 hours) or leads to death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe initial assessment and management of TIA

A

Immediate management:
No longer use ABCD2 score
Give aspirin 300mg immediately, unless patient has bleeding disorder or is taking anticoagulant, patient is already taking low-dose aspirin regularly (continue this until reviewed by specialist) or aspirin is contraindicated

Specialist review:
If more than one TIA (crescendo TIA) or suspected cardioembolic source or severe carotid stenosis discuss need for admission or observation urgently with stroke specialist
If suspected TIA in past 7 days – assessment within 24 hours by specialist stroke physician
If suspected TIA over a week ago – specialist assessment within 7 days

CT brain not recommended unless suspicion of another diagnosis
MRI (including diffusion weighted and blood-sensitive sequences) preferred, on same day as specialist assessment
Urgent carotid doppler (unless not a surgical candidate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Driving rules for TIA/stroke

A

TIA
Don’t drive until seen by specialist
1 TIA – don’t drive for 1 month, no need to inform DVLA
Multiple TIAs – don’t drive for 3 months, need to notify DVLA

Stroke
Don’t drive for at least 1 month, may not need to inform DVLA
Can start driving after 1 month if made adequate clinical recovery, only need to inform DVLA if residual neurological deficit (particularly visual field defect, cognitive defect, impaired limb function)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Describe secondary prevention for TIA/stroke

A

Lifestyle modification

Ischaemic stroke/TIA:
Clopidogrel first-line (without AF)
Aspirin and modified release dipyridamole if clopidogrel contraindicated or not tolerated
Given long-term

High-intensity statin (e.g. atorvastatin)

Anti-hypertensives – target SBP less than 130mmHg (or 140-150 if severe bilateral carotid artery stenosis)

Anticoagulation in AF – DOAC (non-valvular) or warfarin (valvular)

Optimise management of comorbidities e.g. diabetes

Carotid artery stenosis:
Carotid artery endarterectomy recommended if patient has had stroke or TIA in carotid territory (extracranial internal carotid, ophthalmic artery, middle cerebral artery or anterior cerebral artery) and is not severely disabled
Considered if stenosis more than 70% according to European trial or 50% according to North American trial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe the cause and presentation of a subarachnoid haemorrhage

A

Causes:
Traumatic
Spontaneous –
Intracranial aneurysm (85%), associated with hypertension, PKD, Ehlers-Danlos, coarctation of the aorta
AV malformations
Pituitary apoplexy
Mycotic (infective) aneurysm

‘Thunderclap’ headache – acute onset, reaches peak intensity within seconds-minutes, occipital, severe (worst headache of life)
Nausea and vomiting
Photophobia
Neurological symptoms – dysphasia, weakness, visual disturbance, seizures

Reduced consciousness
Neck stiffness
Kernig’s sign – pain with passive knee extension when lying supine and hips and knees flexed

May have ECG changes e.g. ST elevation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
How are subarachnoid haemorrhages assessed initially?
Investigation: Non-contrast CT head first-line – hyperdense blood in basal cisterns, sulci, ventricular system If CT head done within 6 hours of symptom onset and is normal, consider alternative diagnosis If CT head done more than 6 hours after symptom onset and is normal – do an LP at least 12 hours after symptom onset LP – xanthochromia, normal/raised opening pressure If CT shows evidence of SAH immediate referral to neurosurgery Further investigation: CT angiogram to identify vascular lesion +/- digital subtraction angiogram (catheter angiogram)
26
Describe management of confirmed subarachnoid haemorrhage
Supportive: Bed rest Analgesia VTE prophylaxis Discontinuation of anti-thrombotics (reversal or anticoagulation if present) Antiepileptics for seizures Nimodipine – prevent vasospasm Aneurysms are at risk of rebleeding, intervention within 24 hours – interventional radiology coiling (minority get craniotomy and clipping)
27
List potential complications of subarachnoid haemorrhage
Re-bleeding – 10%, most commonly within first 12 hours, should repeat CT if suspected Hydrocephalus – can treat with temporary drain or permanent ventriculoperitoneal shunt Vasospasm Hyponatraemia – SIADH Seizures
28
List red flags for headaches
Infection – immunocompromised, fever, photophobia, neck stiffness Vomiting Thunderclap headache New-onset neurological deficit/cognitive dysfunction Change in personality Impaired consciousness Recent (within 3 months) head trauma Worse with cough, Valsalva Changes with posture Visual disturbance Substantial change in characteristics of headache Wakes from sleep Pregnancy – pre-eclampsia Papilloedema on fundoscopy
29
Describe the presentation and management of tension headaches
Recurrent Mild ache across forehead, band-like Come on and resolve gradually No other symptoms, don’t interfere with ADLs Associated triggers – stress, alcohol, skipping meals, dehydration Management: Simple analgesia – aspirin, paracetamol, NSAID Acupuncture Amitriptyline for prophylaxis (not recommended by NICE)
30
Describe the presentation and management of cluster headaches
Unilateral, excruciating/stabbing/burning pain Ipsilateral to pain – conjunctival injection, lacrimation, nasal congestion, rhinorrhoea, ptosis/miosis Last 15 minutes – 3 hours, 1-2x per day for 4-12 weeks (clusters) MRI with contrast for investigation Neurology referral Acute management – 100% oxygen, SC triptan Prophylaxis – verapamil (?prednisolone)
31
Describe the presentation of migraines
Severe, unilateral, throbbing headache Associated with nausea, photophobia and phonophobia Can last up to 72 hours Classically have aura before migraine – visual, 5-60 minutes of hemianopic disturbance or spreading scintillating scotoma Can have hemiplegic migraines – exclude stroke Triggers – stress, alcohol, lack of food or dehydration, food (cheese, chocolate), menstruation, bright lights
32
Describe the management of migraines
Acute treatment: 1st line – oral triptan + NSAID/paracetamol (in 12-17 year olds consider nasal triptan) If not effective or tolerated give non-oral metoclopramide or prochlorperazine + non-oral NSAID or triptan Prophylaxis: Given if migraines are having significant impact on QOL and daily function e.g., frequent (more than once per week) or are prolonged and severe despite acute treatment One of – propranolol, topiramate (avoid in women of childbearing age), amitriptyline Other options – acupuncture, riboflavin, candesartan, Erenumab (MAB against calcitonin gene-related peptide) Predictable menstrual migraines – frovatriptan or zolmitripan as ‘mini-prophylaxis’
33
Describe the mechanism of action, adverse effects, and contraindications to triptans
5-HT1 agonists Available as oral, nasal, SC Adverse effects – tingling, heat, chest/throat tightness Contraindications – history of or significant risk factors for ischaemic heart disease or cerebrovascular disease
34
Describe the presentation and management of medication overuse headaches
Present for 15 days or more per month (more than every other day) Medications which can trigger – triptans, opioids, paracetamol Management – abruptly withdraw simple analgesics, withdraw opioids gradually Headaches may initially worsen, withdrawal symptoms e.g., vomiting, hypotension, tachycardia, restless, sleep disturbance, anxiety
35
Describe the presentation, cause, and management of trigeminal neuralgia
Compression of trigeminal nerve roots – usually idiopathic, can be tumour/vascular cause Unilateral, brief electric shock-like pain, abrupt onset and termination Limited to one or more division of trigeminal nerve Commonly triggered by light touch, cold, caffeine, citrus fruits or spontaneous Management – carbamazepine first-line
36
Describe the risk factors for and presentation and management of idiopathic intracranial hypertension
Risk factors Obesity Female sex Pregnancy Drugs – COCP, steroids, tetracyclines, retinoids/vitamin A, lithium Presentation – headache, blurred vision, papilloedema, enlarged blind spot, CN VI Management Weight loss Diuretics – acetazolamide Topiramate LP for temporary reduction in ICP Surgery – ventriculoperitoneal shunt, optic nerve sheath decompression to prevent damage
37
What are the indicators of secondary headaches?
Thunderclap – reaches maximal intensity within 1-5 minutes of onset Associated focal neurological deficit Associated systemic features – fever, weight loss, night sweats Age >50
38
Describe the initial assessment of transient loss of consciousness
History – patient and witnesses Circumstances, prodromal symptoms, appearance during event, duration, recovery after event Previous TLoC, PMHx, DHx, FHx Lying and standing BP ECG Cardiovascular or neurological signs Referral for neurological assessment if seizure suspected and cardiovascular assessment if cardiovascular cause suspected
39
List the differential diagnosis of loss of consciousness
Syncope – vasovagal, cardiovascular, orthostatic Seizures Head injury Psychogenic – psychogenic pseudosyncope, psychogenic non-epileptic seizures Rare causes – vertebrobasilar TIA, SAH, cyanotic breath holding spell, subclavian steal syndrome
40
Describe the most common disease patterns in multiple sclerosis
Relapsing-remitting (most common) – episodes of exacerbations of symptoms followed by recovery and periods of stability Secondary progressive – gradual accumulation of disability unrelated to relapses, which become less frequent or stop 2/3 with relapsing-remitting progress to secondary progressive Primary progressive – steady progression and worsening from onset, without remission
41
How is an MS relapse defined?
Onset or new symptoms or worsening of pre-existing symptoms Attributable to demyelinating disease Lasting more than 24 hours After stable period of at least a month
42
Describe the pathophysiology of multiple sclerosis
Largely unknown, risk factors: Genetics Vitamin D deficiency Smoking EBV Female Immune-mediated inflammation in response to environmental triggers in genetically predisposed T-cells attack oligodendrocytes, damaging axons May initially have some re-myelination of axons, eventually irreversible loss of function of affected nerves
43
Describe the presentation and diagnosis of multiple sclerosis
Typical presentation 20-50 Presenting features: Optic neuritis Unthoff’s phenomenon – worsening of symptoms with increase in body temperature (e.g. taking hot bath) Internuclear opthalmoplegia – ipsilesional adduction deficit and contralateral abducting saccade/nystagmus on gaze to contralateral side Sensory – paraesthesias, numbness, trigeminal neuralgia, Lhermitte’s syndrome Spastic weakness Ataxia Tremor Urinary incontinence Sexual dysfunction Diagnosis: Requires evidence of two or more relapses Clinical evidence of two or more lesions or evidence of one lesion and reasonable historical evidence of previous relapse MRI evidence of two lesions (e.g., Dawson fingers) If not enough evidence – CSF for oligoclonal bands
44
Describe the pathophysiology and presentation of internuclear ophthalmoplegia
Lesion involving medial longitudinal fasciculus in paramedian area of midbrain and pons – controls horizontal eye movements via CN III, IV and VI Features – impaired adduction in ipsilateral eye, horizontal nystagmus of abducting eye on contralateral side
45
Describe the management of multiple sclerosis
Acute relapse: High dose steroids (e.g., oral or IV methylprednisolone) for 5 days, shortens length of relapse but does not alter degree of recovery Disease modifying drugs: Typically if 2 relapses in past 2 years and able to walk 100m (if relapsing-remitting) or 10m (in secondary progressive) Options e.g. Natalizumab (alpha-4 beta-1 integrin antagonist) Ocrelizumab (anti-CD20) Fingolimod Beta-interferon Management of complications: Fatigue – amantadine, CBT Spasticity – baclofen, gabapentin, physiotherapy Bladder dysfunction – US, self-catheterisation (if significant residual volume), anticholinergics (if no significant residual volume)
46
Describe the pathophysiology and presentation of Parkinson’s disease
Loss of dopaminergic neurones in the substantia nigra of the basal ganglion Clinical features: Classic triad is bradykinesia, tremor, and rigidity Asymmetrical Bradykinesia/hypokinesia – short, shuffling steps, reduced arm swinging, difficulty initiating movement Tremor – resting, 3-5 Hz, improved with voluntary movement, typically ‘pill-rolling’ Rigidity – lead pipe, cogwheel Reduced dexterity Mask-like face Stooped posture Festinating gait Anosmia Psychiatric features – depression, dementia, psychosis, sleep disturbance Autonomic dysfunction – postural hypotension, constipation, excessive salivation or sweating, urinary dysfunction, sexual dysfunction
47
How can drug-induced Parkinsonism be differentiated from Parkinson’s disease?
Drug-induced: Rapid onset, bilateral Rigidity and rest tremor uncommon
48
How is Parkinson’s disease diagnosed?
Clinical diagnosis If unclear – single photo emission computerised tomography (SPECT)
49
Describe the strategy for management of Parkinson’s disease
First-line: If motor symptoms are affecting quality of life – levodopa If motor symptoms are not affecting quality of life – dopamine agonist, levodopa or monoamine oxidase B inhibitor If continuing to have symptoms with levodopa add dopamine agonist, MAO-B inhibitor or catechol-O-methyl transferase (COMT) inhibitor as an adjunct Levodopa nearly always given with decarboxylase inhibitor (e.g., carbidopa) – prevents peripheral metabolism of levodopa to dopamine outside brain to reduce side effects
50
List adverse effects of levodopa
Dry mouth Anorexia Palpitations Postural hypotension Psychosis Difficult to achieve steady dose – end-of-dose wearing off, on-off phenomenon, dyskinesias at peak dose (dystonia, chorea, athetosis) Important to take consistently
51
List adverse effects of dopamine receptor agonists and give examples
Examples – bromocriptine, ropinirole, cabergoline Ergot-derived (bromocriptine, cabergoline) – associated with pulmonary, retroperitoneal and cardiac fibrosis, perform baseline tests and monitor closely Impulse control disorders Excessive daytime somnolence – may not be able to drive Hallucinations – higher risk than levodopa in older patients Nasal congestion Postural hypotension
52
Describe the mechanism of action of monoamine oxidase B inhibitors in Parkinson’s disease and give examples
Selegiline Inhibits breakdown of dopamine by monoamine oxidase B
53
Describe the mechanism of action of COMT inhibitors in Parkinson’s disease and give examples
Entacapone, tolcapone COMT is involved in breakdown of dopamine – inhibit breakdown Used in conjunction with levodopa in patients with established Parkinson’s disease
54
List causes of Parkinsonism/differential diagnosis of Parkinson’s disease
Parkinson’s disease Drug induced – antipsychotics, antiemetics (metoclopramide) Progressive supranuclear palsy – unsteadiness, dysphagia, gaze palsies Multiple system atrophy – unsteadiness, falls, autonomic dysfunction Wilson’s disease Lewy body dementia Essential tremor – increases on action, improved at rest, improved with alcohol, bilateral, not confined to hands
55
Why is it important to avoid missing doses of anti-Parkinsonian medications?
Missing doses can cause akinesia (freezing) and can precipitate neuroleptic malignant syndrome
56
List causes of peripheral neuropathy
Predominantly motor loss: Guillain-Barre syndrome Poryphria Lead poisoning Hereditary sensorimotor neuropathies – Charcot-Marie-Tooth Diphtheria Predominantly sensory loss: Diabetes Uraemia Leprosy Alcoholism Vitamin B12 deficiency Amyloidosis
57
Describe the functions of the spinal tracts
Ascending tracts: Anterior spinothalamic tract – touch and pressure Lateral spinothalamic tract – pain and temperature Spinocerebellar tracts – proprioception Descending tracts: Pyramidal tracts – voluntary control of muscles Extrapyramidal tracts – involuntary and automatic control of muscles (tone, balance, posture)
58
Causes of mononeuropathies
Most common – injury/compression More rarely toxic/metabolic – tend to be mononeuritis multiplex, multiple single nerves affected sequentially Diabetes Drugs Vasculitis Infection – HIV/Lyme
59
What is the most common compression neuropathy? How does it present?
Radial nerve – ‘Saturday night palsy’ Presentation – wrist/finger drop, usually painless Sensory loss in radial nerve distribution (proximal half of thumb, 1st, 2nd and lateral half of 3rd finger)
60
Which nerve palsy causes foot drop?
Common peroneal nerve
61
How should peripheral neuropathies be investigated?
Bloods – Glucose, FBC, U&Es, LFTs, TFTs, B12, folate, protein electrophoresis LP – not routine in length dependent neuropathy Nerve conduction studies
62
Describe the presentation, diagnosis, and management of Guillain-Barre syndrome
Acute rapidly progressive flaccid paralysis Weak proximally and distally Prominent pain/sensory symptoms +/- respiratory, bulbar, autonomic involvement Areflexic Post-infective - classically campylobacter jejuni Diagnosis – clinical + raised protein in CSF (normal WCC), nerve conduction studies Treatment – IV Igs or plasma exchange
63
Describe the pathophysiology and clinical presentation of myasthenia gravis
Antibodies to acetylcholine receptors Muscle fatigability – weaker during activity, improve with rest Extraocular muscle weakness – diplopia Proximal muscle weakness – face, neck, limb girdle Ptosis – exacerbated by repeated blinking Dysphagia Associations: Thymoma – 15% Autoimmune disorders – pernicious anaemia, autoimmune thyroid disorders, rheumatoid, SLE
64
How is myasthenia gravis diagnosed and managed?
Diagnosis: Single fibre electromyography CT thorax to exclude thymoma CK normal Antibodies to acetylcholine receptors Tensilon test – IV edrophonium reduces muscle weakness temporarily (not done anymore) Management: Long-acting acetylcholinesterase inhibitors – pyridostigmine first-line Longer term often need immunosuppression with prednisolone, azathioprine, cyclosporine etc. Thymectomy Management of myasthenic crisis: Plasmapheresis IV Igs
65
List drugs which can exacerbate symptoms of myasthenic gravis
Penicillamine Quinidine Beta-blockers Lithium Phenytoin Antibiotics – gentamicin, macrolides, quinolones, tetracyclines